ClinicalTrials.gg
RecruitingNCT07134881Updated Nov 17, 2026

Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)

An interventional study of Careverse and Usual Care in Paliative Care, Advance Care Planning and Digital Education Interventions, sponsored by National University of Singapore. Recruiting at 1 site in Singapore. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by National University of Singapore · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 2 months later.
Updated Nov 17, 20261 site added1 site removedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

The goal of this two-armed, parallel-design, pre-/post-intervention assessment clinical trial is to learn if a digital and interactive website helps to improve advance care planning (ACP) engagement among caregivers of patients with serious illness. The main questions it aims to answer are:

Does the website increase ACP engagement of caregivers of patients with serious illness? Researchers will compare the digital and interactive website to the usual care (a digital booklet) to see if the digital intervention works to improve ACP engagement among caregivers.

Participants who are caregivers will:

  • Be introduced to a digital website and asked to explore the site over the course of the study.
  • Complete four self-administered questionnaires (baseline, one-week, six-week, and six-month).

Participants who are patients will not have any intervention assigned and will only have their observational data collected through four interviewer-administered questionnaires (baseline, one-week, six-week, and six-month)

02

Conditions studied

  • Paliative Care
  • Advance Care Planning
  • Digital Education Interventions
  • Values, Social
  • Goals of Care

Keywords

  • randomised control trial
  • digital intervention
  • advance care planning
  • goals of care
  • palliative care
03

In context

Lead sponsor

National University of Singapore is the lead sponsor of 212 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

1. Patient Participants Inclusion Criteria:

  1. Singapore resident aged 21years and above,
  2. patient able to identify one main caregiver in the care and medical decision-making for the patient;
  3. patient able to communicate in either English, Chinese, Malay or Tamil;
  4. patient meeting one of the following illness criteria: 4a. Patients with brain tumours: histological and/or radiological diagnosis of glioma or .

4b. Patients with spontaneous intracerebral haemorrhage (SICH) based on radiological diagnosis of SICH on baseline computed-tomographic scans.

4c. Patients with CKD Stage 4 and 5, identified at G4 or G5 of CKD, (GFR) 30 ml/min or less, inclusive of kidney failure on kidney replacement therapy; and (5) Physicians assessment that ACP is appropriate for the patient by physicians.* (*) The attending clinicians may base the assessment of ACP appropriateness on several factors in addition to high mortality risk. As a baseline, clinicians are asked to base their assessment of high mortality risk using the validated "Surprise" question.

2. Patient participants Exclusion Criteria:

  1. Patients unable to identify a caregiver who is a medical decision-maker,
  2. Patients are currently or was previously healthcare workers; or
  3. Patients are diagnosed with dementia or deemed cognitively impaired as determined by the Abbreviated Mental Test.

3. Caregiver Participants Inclusion Criteria:

  1. caregivers are identified as a medical decision-maker for the patient
  2. Singapore resident aged 21 years and above; and
  3. able to communicate in English

4. Caregiver Participants Exclusion Criteria:

  1. caregivers are currently or were previously healthcare workers;
  2. caregivers not involved in primary care of the patient (including providing care to the patient, supervision of care, or involved in making decisions regarding treatment the patient receives); or
  3. caregivers diagnosed with dementia.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Brain metastases

Cancer deposits in the brain from a cancer that started elsewhere in the body (CNS metastases include the spinal cord).

Studies differ: some leave out any brain metastases, some accept ones treated and stable for some weeks. Check what this study allows.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Comparator arm

    For caregiver participants: Usual care. For patient participants: usual care, as prescribed by the clinical care team, is unaffected by the study design and we only conduct observational measurements of patient participants during the course of the study.

    Other: Usual Care

  • Experimental
    Intervention arm

    For caregiver participants: Enrolled caregiver participants randomised in the intervention arm will be directed to the intervention digital website and guided through the signup process. Once logged in, they are asked to explore and use the website contents and tools in their own time. For patient participants: usual care, as prescribed by the clinical care team, is unaffected by the study design and we only conduct observational measurements of patient participants during the course of the study.

    Behavioral: Careverse

Interventions

  • BehavioralCareverse

    Careverse is a digital psychoeducational website designed to assist caregivers and patients to clarify their values, end-of-life preferences, enable surrogates to further their understanding of the patient's wishes, and prepare surrogates for the role and responsibilities of a medical decision maker. The intervention consists of values elicitation tools, educational materials, and testimonies. The participants will receive guides on how to initiate/re-introduce discussions about end-of-life wishes with their loved ones and clinicians.

  • OtherUsual Care

    Caregivers in the comparator arm will receive a digital version of standard advanced care planning education material prepared by Agency of Integrated Care. The ACP Workbook is created by AIC to help individuals explore their values, care preferences, and end-of-life goals in a structured, reflective way.

06

What researchers measure

Primary outcomes

  1. Advance Care Planning Engagement Survey for Surrogate Decision-Maker

    The 17-item ACP Surrogate Decision Making Instrument (ACP-17 SDM) developed by Sudore et. al., is a validated questionnaire designed to assess how engaged surrogate decision makers (SDMs) are in the advance care planning process. The ACP-17 SDM measures engagement across three domains: 1) Serving as SDM (7 items), 2) Contemplation (4 items), and 3) Readiness (6 items). Each item is answered on a 5-point Likert scale (1 = not at all/never, to 5 = extremely/A lot), and higher mean scores (range: 1.0 - 5.0) indicate higher engagement in ACP by the surrogate. Van Scoy, Lauren J., et al. "Adaptation and preliminary validation of the advance care planning engagement survey for surrogate decision makers." Journal of pain and symptom management 57.5 (2019): 980-988.

    Time frame: Baseline, 1-week, and 6-week

Secondary outcomes

  1. Satisfaction with care

    We measure patients and caregivers' satisfaction with care that they (or their patient) received using the Short Assessment of Patient Satisfaction (SAPS), a brief, validated, and generic 7-item questionnaire designed to efficiently measure patient satisfaction across a range of health care settings.\[49-51\] Each question is rated on a 5-point Likert scale (ranging from 0 to 4), and the items cover key domains of patient satisfaction including:1) Satisfaction with treatment, 2) Explanation of treatment results, 3) Clinician care and thoroughness, 4) Involvement in decision-making, 5) Respect received from the clinician, 6) Adequacy of time with the clinician, and 7) Overall satisfaction with care received. Total scores range from 0 to 28, and higher scores indicate greater satisfaction.

    Time frame: Baseline, 6-week, and 6-month

  2. Satisfaction with care - Feeling Heard and Understood

    We measure how well patients and caregivers feel heard and understood by those caring for them in the hospital environment using the following point-of-care item: "Over the past 1(6) months, how much have you felt heard and understood by the doctors, nurses and hospital staff?". Response is rated on a 5-point scale (completely, quite a bit, moderately, slightly, not at all). Responses are reverse-coded, ranging from 1 - 5, with higher score indicates better quality of care. Gramling, R., et al., Feeling Heard and Understood: A Patient-Reported Quality Measure for the Inpatient Palliative Care Setting. Journal of Pain and Symptom Management, 2016. 51(2): p. 150-154.

    Time frame: Baseline, 6-week, and 6-month

  3. Goals of care

    We assess participants' preferences for aggressive care using goals of care questions adapted from the CanCORS Study. Participants were asked to trade-off between life-extension treatments or 1) those that miminise pain/discomfort and 2) those that were less costly. Participants responded on a scale of 1 to 9, where 1 represented maximal life extension with severe pain or discomfort (or with higher costs), 5 represented moderate life extension and moderate pain or discomfort (or moderate cost), and 9 indicated no life extension but minimal pain or discomfort (or lower costs). Scores 1 to 4 were categorized as prioritizing life extension, and scores 6 to 9 were categorized as prioritizing symptom management or cost containment. Malin, J.L., et al., Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer, 2006. 14(8): p. 837-48.

    Time frame: Baseline, 1-week, 6-week, and 6-month

  4. Caregivers Wellbeing

    We assess caregiver's quality of life using the Singapore Caregivers Quality of Life Scale (SCQOLS), a validated instrument developed specifically to assess the quality of life (QoL) of family caregivers of patients with advanced illnesses in Singapore. The 10-item SCQOLs measures five domains of quality of life of family caregivers of patients: (1) Physical Well-being (2 items); (2) Mental Well-being (2 items); (3) Experience \& Meaning (2 items); (4) Impact on Daily Life (2 items) (5) Financial Well-being (2 items). Each item is rated on a 5-point scale, ranging from 0 (Not at All) to 4 (Very Much). Item scores are rescaled and summed. Total scores range from 0 - 100, with higher scores indicating better quality of life. Cheung, Yin Bun, et al. "Two valid and reliable short forms of the Singapore caregiver quality of life scale were developed: SCQOLS-10 and SCQOLS-15." Journal of Clinical Epidemiology 121 (2020): 101-108.

    Time frame: Baseline, 1-week, 6-week, and 6-month

  5. Caregiver quality of life - Mental health

    Symptoms of depression and anxiety are measured using the 4-item Patient Health Questionnaire (PHQ-4), an ultra-brief, validated self-report instrument designed to screen for symptoms of both depression and anxiety in clinical and non-clinical populations. The PHQ-4 has four items: two for depression ("little interest or pleasure in doing things"; "feeling down, depressed, or hopeless") and two for anxiety ("feeling nervous, anxious or on edge"; "not being able to stop or control worrying"). Each item is rated based on symptom frequency over the past two weeks using a 4-point Likert scale, from 0 (not at all) to 3 (nearly every day). A subscale score of 3 or greater suggests possible anxiety or depression, while total distress is categorized as: normal (0-2), mild (3-5), moderate (6-8), and severe (9-12). Kroenke, K., et al., An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics, 2009. 50(6): p. 613-21.

    Time frame: Baseline, 1-week, 6-week, and 6-month

  6. Caregiver dyadic relationship

    We assess the caregiving relationship between the caregiver and patient using the Dyadic Relationship Scale (DRS), a validated instrument measuring negative dyadic strain and positive dyadic interaction. \[63\] The caregiver version includes 11 items and are rated on a four-point scale (0 = strongly disagree to 3 = strongly agree). Total scores range from 0-33, with higher scores indicate better dyadic relationship. Sebern MD, Whitlatch CJ. Dyadic relationship scale: a measure of the impact of the provision and receipt of family care. Gerontologist. 2007 Dec;47(6):741-51. doi: 10.1093/geront/47.6.741. PMID: 18192628.

    Time frame: Baseline, 1-week, 6-week, and 6-month

  7. Patient Healthcare Utilisation

    Electronic medical records will be reviewed to find the number of inpatient admissions, urgent care visits, ED visits, hospitalizations, outpatient visits and aggressive treatment utilisation (e.g. Intubation, CPR, Surgery).

    Time frame: Within six months pre-and post-intervention OR 12 months before death

  8. Patient quality of life

    We assess patient's quality of life using the EQ-5D-5L instrument, a simple, and standardised measure of health status. five dimensions (mobility, self-care, usual activities, pain / discomfort and anxiety / depression), on five response levels: 1-no problems, 2-slight problems, 3-moderate problems, 4-severe problems, 5-unable to/extreme problems. The overall health states can be converted to an index value, ranging from 0 (worst possible health state) to 1 ((best possible health state) using a value set. Herdman, Michael, et al. "Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)." Quality of life research 20.10 (2011): 1727-1736.

    Time frame: Baseline, 1-week, 6-week, and 6-month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Huynh VA, Koh GCH, Lim MJR, Liew TM, Nga VDW, Yeo TT, Chan N, Tan JN, Sym FP. Navigating Advanced Illness Goals And Treatment with Digital Engagement (NAVIGATE): a protocol for a randomised controlled trial of a website for caregivers of patients with serious illness. Trials. 2026 Jun 25. doi: 10.1186/s13063-026-09876-0. Online ahead of print. PubMed 42351230 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — The study gathers sensitive medical and personal data from patients and caregivers that cannot be disclosed publicly.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2025 (actual). Primary completion is estimated for Jul 2027, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2025
First posted
Aug 21, 2025
StartActual
Aug 27, 2025
Primary completionEst.
Jul 31, 2027
CompletionEst.
Jul 31, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • National University Hospital · Singapore, Singapore
Show 1 removed
  • National University Hospital · Singapore, Singapore
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    1 site added, 1 site removed
    Show site
    • National University Hospital · Singapore, Singapore
    Show 1 removed
    • National University Hospital · Singapore, Singapore
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07134881
Responsible party
Gerald Koh (Professor, National University of Singapore) — Principal investigator
First posted
Aug 21, 2025
Start date
Aug 27, 2025
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Gerald Choon Huat Koh, PhD(FM)
principal investigator · Saw Swee Hock School of Public Health, National University of Singapore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion